Loading...
XASE
AMS
Market cap13mUSD
Dec 04, Last price  
2.07USD
1D
-1.43%
1Q
-17.53%
Jan 2017
-38.21%
Name

American Shared Hospital Services

Chart & Performance

D1W1MN
XASE:AMS chart
P/E
6.16
P/S
0.48
EPS
0.34
Div Yield, %
—
Shrs. gr., 5y
2.48%
Rev. gr., 5y
6.58%
Revenues
28m
+32.90%
18,231,00020,385,00022,622,00019,099,00016,768,00016,675,00022,221,00017,048,00017,584,00015,417,00016,548,00018,700,00019,556,00019,714,00020,605,00017,837,00017,628,00019,746,00021,325,00028,340,000
Net income
2m
+258.36%
1,767,0001,656,000951,000477,000-188,00057,000506,00038,000-312,000-952,000-1,522,000930,0001,923,0001,023,0001,430,000-7,716,000678,0001,328,000610,0002,186,000
CFO
167k
-97.08%
8,480,0009,164,0008,484,0008,947,0007,704,0007,184,0006,823,0006,871,0008,076,0006,773,0008,548,0008,378,0007,853,0008,062,0008,047,0009,745,0006,267,0007,235,0005,718,000167,000
Dividend
Jun 28, 20070.0475 USD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

American Shared Hospital Services leases radiosurgery and radiation therapy equipment to health care providers. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. As of December 31, 2021, it had 115 operating Gamma Knife units located in the United States, as well as two in South America in Lima, Peru and Guayaquil, Ecuador. The company also operates one PBRT system. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.
URL
https://ashs.com/
IPO date
Jul 04, 1984
Employees
28
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT